Cell Source, Inc. (CLCS)
OTCMKTS · Delayed Price · Currency is USD
0.8200
-0.0200 (-2.38%)
May 6, 2026, 12:40 PM EST
Cell Source Market Cap
Cell Source has a market cap or net worth of $57.07 million as of May 6, 2026. Its market cap has increased by 161.80% in one year.
Market Cap
57.07M
Enterprise Value
67.58M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.82
Market Cap Chart
Since July 1, 2014, Cell Source's market cap has increased from 36.03M to 57.07M, an increase of 58.40%. That is a compound annual growth rate of 3.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 57.07M | 133.81% |
| Dec 31, 2025 | 24.41M | 59.96% |
| Dec 31, 2024 | 15.26M | -14.98% |
| Dec 27, 2023 | 17.95M | -40.09% |
| Dec 29, 2022 | 29.96M | -30.67% |
| Dec 31, 2021 | 43.22M | -32.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glorywin Entertainment Group | 149.60M |
| HST Global | 140.02M |
| NDT Pharmaceuticals | 114.12M |
| BioStem Technologies | 74.11M |
| Nuo Therapeutics | 58.08M |
| ProText Mobility | 53.63M |
| Vicapsys Life Sciences | 47.26M |
| Sangamo Therapeutics | 46.15M |